Relating to: cost-sharing cap on epinephrine delivery systems under health insurance policies and plans. (FE)

AB 775 limits out-of-pocket costs for epinephrine delivery systems (like EpiPens) under specific health insurance plans. It caps cost-sharing at $60 for two doses of these devices, applying to disability insurance policies and self-insured health plans covering government entities (such as state agencies, schools, or local governments). Insurers cannot charge more than $60 per two-dose supply regardless of the device type, though they may charge less. The law takes effect for plan years beginning after its publication date.